Large-scale testing (Phase 3)Study completedNCT00910247What this trial is testingEslicarbazepine Acetate Monotherapy Long Term StudyWho this might be right forEpilepsy Sumitomo Pharma America, Inc. 274
Not applicableUnknownNCT03457961What this trial is testingPost-market Study of AMPA Receptor Antagonists for Epilepsy Patients in Hong KongWho this might be right forFocal EpilepsyGeneralized EpilepsyPartial Seizures, Simple Chinese University of Hong Kong 80
Large-scale testing (Phase 3)Study completedNCT00866775What this trial is testingSafety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic DrugsWho this might be right forEpilepsy With Simple or Complex Partial Onset Seizures Sumitomo Pharma America, Inc. 193
Large-scale testing (Phase 3)Study completedNCT00292461What this trial is testingEvaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized SeizuresWho this might be right forEpilepsy Eisai Inc. 64
Large-scale testing (Phase 3)Study completedNCT01963208What this trial is testingPhase 3 Study of Adjunctive Ganaxolone in Adults With Drug-resistant Partial Onset Seizures and Open-label ExtensionWho this might be right forDrug Resistant Partial Onset Seizure Marinus Pharmaceuticals 405
Large-scale testing (Phase 3)Study completedNCT01749046What this trial is testingRemegal Fixed Dose as Adjunctive Therapy in Patients With Partial SeizuresWho this might be right forEpilepsySimple Partial SeizuresComplex Partial Seizures+1 more Valexfarm 224
Large-scale testing (Phase 3)Ended earlyNCT02519439What this trial is testingA Two-year Open-label Extension Study of Ganaxolone in Patients With Drug-resistant Partial-onset SeizuresWho this might be right forDrug Resistant Partial Onset Seizure Marinus Pharmaceuticals 26
Large-scale testing (Phase 3)Study completedNCT00740623What this trial is testingThe Effectiveness, Safety, and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset Seizures.Who this might be right forEpilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more SK Life Science, Inc. 547
Post-approval studies (Phase 4)Ended earlyNCT00215215What this trial is testingEffectiveness Study Comparing Treatment With Drug(s) or Adjunctive VNS Therapy for Pharmacoresistant Partial SeizuresWho this might be right forEpilepsies, Partial Cyberonics, Inc. 360
Large-scale testing (Phase 3)Study completedNCT00744731What this trial is testingAn Open-Label Extension Study of the Safety and Tolerability of Carisbamate as Add-On Therapy in Patients With Partial Onset SeizuresWho this might be right forEpilepsy, Partial, MotorEpilepsy, Complex PartialEpilepsy, Simple Partial+1 more SK Life Science, Inc. 403